Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 30: 439-441, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dods, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dods, R. F.

Clinical Chemistry, Vol 30, 439-441, Copyright © 1984 by American Association for Clinical Chemistry

Early detection of myocardial infarction by an immunoradiometric procedure for creatine kinase MB

RF Dods

I investigated the diagnostic efficacy of the Embria-CK immunoradiometric assay (IRMA) in detecting myocardial infarction, using a single blood sample drawn at hospital admission 0 to 10 h after the onset of chest pain and serial testing over a 24- to 48-h interval after hospital admission. The sensitivity, specificity, and efficiency for hospital admission samples were 87.5, 83.3, and 85.0%, respectively, and for serial testing, 100, 79.2, and 87.5%, respectively. The diagnostic efficacy was comparable to that of electrophoresis and significantly better than the Du Pont CK-MB method.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.